Maria Varela, who has muscular dystrophy, recently began making posters for children with disabilities who attend Waggoner Elementary. Subscribe to continue reading, or log in . Mallory Wyatt ...

Posters presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference highlight the complex care needs and physical activity barriers for individuals with myotonic dystrophy.

Posters will be showcased during the Poster and Networking Reception in the Trinity Exhibit Hall from March 16-18, 2025, 6 – 8 PM CT. The full MDA 2025 Conference program is available here ...

Title: Mechanistic Characterization of Enhanced Delivery Oligonucleotide (EDO) Platform Poster Number: #P21 Presenter: Jane Larkindale, DPhil, Vice President, Clinical Science ...

Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found tolerable and showed signs of efficacy in a real-world cohort.